Trastuzumab Deruxtecan for Breast Cancer. Reply
- PMID: 35704496
- DOI: 10.1056/NEJMc2205309
Trastuzumab Deruxtecan for Breast Cancer. Reply
Comment on
-
Trastuzumab Deruxtecan for Breast Cancer.N Engl J Med. 2022 Jun 16;386(24):2346-2347. doi: 10.1056/NEJMc2205309. N Engl J Med. 2022. PMID: 35704495 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical